Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mismatch repair dissection by in vivo RNAi reveals dose-dependent modulators of somatic instability and proteome remodeling in Huntington's disease.

bioRxiv : the preprint server for biology·2026
Same author

Precision RNAi for Fibrodysplasia Ossificans Progressiva: a combinatorial, unimolecular, allele selective approach.

Research square·2026
Same author

Social Media Influencers and Mental Health Messaging: A Scoping Review.

Health communication·2026
Same author

Fully Modified SpyCas9 Guide RNAs Enable Robust Genome Editing In Cells and In Vivo.

bioRxiv : the preprint server for biology·2026
Same author

C57BL/6 BAC-CAG Huntington's disease mice show somatic CAG expansion and responses to small interfering RNAs comparable to the FVB strain.

bioRxiv : the preprint server for biology·2026
Same author

Divalent siRNA for prion disease.

Nucleic acids research·2026

相关实验视频

Updated: Jul 3, 2025

Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits
09:17

Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits

Published on: March 14, 2018

10.2K

一种结合方法来实现中枢神经系统选择性RNAi.

Chantal M Ferguson1, Bruno M D C Godinho1, Dimas Echeverria1

  • 1RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.

Nucleic acids research
|February 13, 2024
PubMed
概括

化学修饰的小干扰RNAs (siRNAs) 可以使中枢神经系统 (CNS) 中的基因沉默. 研究人员开发了抗siRNAs来阻止不必要的肝脏基因沉默,从而实现中枢神经系统选择性RNA干扰的潜在临床用途.

更多相关视频

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.7K
Assaying Circuit Specific Regulation of Adult Hippocampal Neural Precursor Cells
08:52

Assaying Circuit Specific Regulation of Adult Hippocampal Neural Precursor Cells

Published on: July 24, 2019

6.5K

相关实验视频

Last Updated: Jul 3, 2025

Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits
09:17

Combining Optogenetics with Artificial microRNAs to Characterize the Effects of Gene Knockdown on Presynaptic Function within Intact Neuronal Circuits

Published on: March 14, 2018

10.2K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.7K
Assaying Circuit Specific Regulation of Adult Hippocampal Neural Precursor Cells
08:52

Assaying Circuit Specific Regulation of Adult Hippocampal Neural Precursor Cells

Published on: July 24, 2019

6.5K

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • RNA干扰 (RNAi) 是一种通过小干扰RNA (siRNA) 调节基因表达的自然过程.
  • 橄核酸的分发和清除受药方和化学结构的影响,可能会导致肝脏等器官的非目标效应.
  • 双向siRNAs (di-siRNAs) 被注射到脑脊液 (CSF) 中,有效地使中枢神经系统中的基因沉默,但可以在肝脏中积累.

研究的目的:

  • 开发一种方法,在中枢神经系统中实现选择性基因沉默,同时防止肝脏的非目标效应.
  • 为了证明抗siRNAs的同时使用可以减轻特定器官中不必要的基因调制.

主要方法:

  • 利用双价性siRNAs (di-siRNAs) 通过CSF进行中枢神经系统基因沉默.
  • 采用肝脏向,GalNAc结合的抗siRNAs作为抑制剂来阻止非向效应.
  • 用APOE基因作为模型目标来评估肝脏沉默及其缓解.

主要成果:

  • 将di-siRNAs注射到脑脊液中,会在整个中枢神经系统中诱导强大的基因沉默.
  • 在肝脏中发生了无意的di-siRNA积累和基因沉默.
  • 服用向肝脏的抗siRNAs成功地阻断了肝脏APOE沉默,而不影响中枢神经系统活动.
  • 通过有针对性的抑制非目标效应,实现了完全中枢神经系统选择性的基因沉默.

结论:

  • 针对性抗siRNAs与siRNAs的同时使用提供了一种实现组织特异性基因沉默的策略.
  • 这种方法提高了RNA干扰疗法的安全性和潜在的临床可翻译性,通过防止非目标器官的积累和活动.
  • 开发的方法可以适应以实现各种器官组合的组织选择性,而不仅仅是中枢神经系统和肝脏.